dronabinol has been researched along with caffeine in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (18.52) | 18.7374 |
| 1990's | 3 (11.11) | 18.2507 |
| 2000's | 10 (37.04) | 29.6817 |
| 2010's | 7 (25.93) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Consroe, P; Jones, B; Laird, H | 1 |
| Evans, EB; Wenger, GR | 1 |
| Abkowitz, JL; Labbe, RF; Little, RE; Phillips, EL; Uhl, CN | 1 |
| Appel, JB; Greenberg, I; Kuhn, DM | 1 |
| Forney, RB | 1 |
| Davis, TR; Dews, PB; Kensler, CJ | 1 |
| Garcia, MM; Harlan, RE | 1 |
| Partridge, B; Schenk, S | 1 |
| Li, M; McMillan, DE | 1 |
| Caboche, J; Girault, JA; Hervé, D; Pagès, C; Valjent, E | 1 |
| Andersen, ML; Papale, LA; Perry, JC; Tufik, S | 1 |
| Araújo, JR; Gonçalves, P; Martel, F | 1 |
| Araújo, JR; Gonçalves, P; Martel, F; Pinho, MJ | 1 |
| Hoffman, AF; Kawamura, M; Laaris, N; Lupica, CR; Masino, SA | 1 |
| Assaife-Lopes, N; Brett, RR; Pratt, JA; Ribeiro, JA; Sebastião, AM; Sousa, VC | 1 |
| Biagini, R; Robertson, S; Sammons, D; Smith, J; Snawder, J | 1 |
| Ferré, S; Goldberg, SR; Panlilio, LV; Schindler, CW; Thorndike, EB; Yasar, S | 1 |
| Campen, KA; McNatty, KP; Pitman, JL | 1 |
| Bastiani, MF; da Silva Moreira, IC; do Nascimento, CA; Hahn, RZ; Linden, R; Lizot, LLF; Meireles, YF; Schneider, A; Viana, MF | 1 |
| Bansal, S; Paine, MF; Spindle, TR; Thummel, KE; Unadkat, JD; Vandrey, R; Weerts, EM; Zamarripa, CA | 1 |
2 review(s) available for dronabinol and caffeine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drugs of abuse and immediate-early genes in the forebrain.
Topics: Amphetamines; Animals; Caffeine; Cocaine; Dronabinol; Gene Expression Regulation; Genes, Immediate-Early; Humans; Illicit Drugs; Immediate-Early Proteins; Morphine; Nicotine; Prosencephalon; Substance-Related Disorders | 1998 |
1 trial(s) available for dronabinol and caffeine
| Article | Year |
|---|---|
International seminar research on alcohol, drugs and driving.
Topics: Alcohol Drinking; Auditory Perception; Automobile Driving; Caffeine; Chlordiazepoxide; Clinical Trials as Topic; Color Perception Tests; Dextroamphetamine; Diazepam; Diphenhydramine; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Ethanol; Feedback; Glutethimide; Histamine H1 Antagonists; Humans; Meprobamate; Motor Skills; Nortriptyline; Placebos; Postural Balance; Secobarbital; Tripelennamine | 1973 |
24 other study(ies) available for dronabinol and caffeine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
EEG and behavioral effects of delta9-tetrahydrocannabinol in combination with stimulant drugs in rabbits.
Topics: Animals; Apomorphine; Ataxia; Behavior, Animal; Caffeine; Cerebral Cortex; Cocaine; Dronabinol; Drug Interactions; Electroencephalography; Hippocampus; Humans; Methamphetamine; Motor Activity; Posture; Rabbits; Stereotyped Behavior | 1976 |
The effects of cocaine in combination with other drugs of abuse on schedule-controlled behavior in the pigeon.
Topics: Animals; Caffeine; Cocaine; Columbidae; Conditioning, Operant; Dextroamphetamine; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Illicit Drugs; Male; Morphine; Reinforcement Schedule | 1990 |
Agreement between laboratory tests and self-reports of alcohol, tobacco, caffeine, marijuana and other drug use in post-partum women.
Topics: Adult; Alanine Transaminase; Alcohol Drinking; Aspartate Aminotransferases; Blood Cell Count; Caffeine; Dronabinol; Female; gamma-Glutamyltransferase; Humans; Marijuana Abuse; Nicotine; Pregnancy; Psychotropic Drugs; Puerperal Disorders; Smoking; Substance-Related Disorders; Thiocyanates; Truth Disclosure | 1986 |
An analysis of some discriminative properties of d-amphetamine.
Topics: Adrenergic Agents; Animals; Behavior, Animal; Caffeine; Cues; Dextroamphetamine; Discrimination Learning; Dose-Response Relationship, Drug; Dronabinol; Injections, Intraperitoneal; Lysergic Acid Diethylamide; Male; Mescaline; Methamphetamine; Methyltyrosines; Psilocybin; Rats; Time Factors | 1974 |
Comparison of behavioral effects of nicotine, d-amphetamine, caffeine and dimethylheptyl tetrahydrocannabinol in squirrel monkeys.
Topics: Animals; Avoidance Learning; Behavior, Animal; Caffeine; Cannabis; Dextroamphetamine; Dronabinol; Haplorhini; Motor Activity; Nicotine | 1973 |
Cocaine-seeking produced by experimenter-administered drug injections: dose-effect relationships in rats.
Topics: Animals; Caffeine; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Dronabinol; Hallucinogens; Male; Morphine; Narcotics; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Reinforcement Schedule | 1999 |
Retention of sequential drug discriminations under fixed-interval schedules for long time periods without training.
Topics: Animals; Behavior, Animal; Caffeine; Central Nervous System Depressants; Central Nervous System Stimulants; Chlordiazepoxide; Cocaine; Columbidae; Dextroamphetamine; Discrimination Learning; Dose-Response Relationship, Drug; Dronabinol; Generalization, Psychological; Male; Morphine; Nicotine; Pentobarbital; Reinforcement Schedule | 2003 |
Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain.
Topics: Adrenergic Uptake Inhibitors; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Benzazepines; Brain; Caffeine; Central Nervous System Stimulants; Cocaine; Desipramine; Dopamine Antagonists; Dronabinol; Enzyme Activation; Fluoxetine; Immunohistochemistry; Male; Mice; Mitogen-Activated Protein Kinases; Morphine; Muscarinic Antagonists; Neurons; Nicotine; Nicotinic Agonists; Scopolamine; Selective Serotonin Reuptake Inhibitors | 2004 |
Effects of different substance misuse in genital reflexes of paradoxical sleep deprived male rats.
Topics: Analysis of Variance; Animals; Caffeine; Central Nervous System Depressants; Central Nervous System Stimulants; Disease Models, Animal; Dronabinol; Ejaculation; Ethanol; Genitalia, Male; Male; Penile Erection; Psychotropic Drugs; Rats; Rats, Wistar; Reflex; Sexual Behavior, Animal; Sleep Deprivation | 2007 |
Modulation of glucose uptake in a human choriocarcinoma cell line (BeWo) by dietary bioactive compounds and drugs of abuse.
Topics: Acetaldehyde; Amphetamine; Biological Transport; Caffeine; Cell Line, Tumor; Cell Survival; Choriocarcinoma; Cytochalasin B; Deoxyglucose; Diet; Dronabinol; Ethanol; Flavonoids; Glucose; Humans; Illicit Drugs; Kinetics; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Phenols; Polyphenols; Theophylline; Trophoblasts | 2008 |
Modulation of butyrate transport in Caco-2 cells.
Topics: 2,4-Dinitrophenol; 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Acetaldehyde; Acids, Acyclic; Aspirin; Biological Transport, Active; Butyrates; Caco-2 Cells; Caffeine; Cell Survival; Dronabinol; Gene Expression; Humans; Hydrogen-Ion Concentration; Indomethacin; Ions; Kinetics; Monocarboxylic Acid Transporters; N-Methyl-3,4-methylenedioxyamphetamine; Sodium Azide; Symporters; Theophylline | 2009 |
Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors.
Topics: Adenosine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analysis of Variance; Animals; Benzoxazines; Biophysics; CA1 Region, Hippocampal; Caffeine; Calcium Channel Blockers; Dronabinol; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Glutamic Acid; In Vitro Techniques; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Naphthalenes; Neural Inhibition; Neurons; Patch-Clamp Techniques; Phosphinic Acids; Picrotoxin; Piperidines; Presynaptic Terminals; Propanolamines; Pyrazoles; Quinoxalines; Receptor, Adenosine A1; Receptor, Cannabinoid, CB1; Xanthines | 2010 |
Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.
Topics: Adenosine A1 Receptor Antagonists; Animals; Caffeine; Chronic Disease; Dronabinol; Hippocampus; Male; Memory; Memory Disorders; Mice; Mice, Inbred C57BL; Psychotropic Drugs; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptor, Cannabinoid, CB1 | 2011 |
Measurement of multiple drugs in urine, water, and on surfaces using fluorescence covalent microbead immunosorbent assay.
Topics: Caffeine; Cocaine; Dronabinol; Fluorescence; Humans; Illicit Drugs; Immunosorbent Techniques; Methamphetamine; Microspheres; Oxycodone; Substance Abuse Detection; Water | 2010 |
Combined effects of THC and caffeine on working memory in rats.
Topics: Adenosine A1 Receptor Antagonists; Animals; Caffeine; Dronabinol; Drug Synergism; Male; Memory, Short-Term; Rats; Rats, Long-Evans; Receptor, Adenosine A1; Theophylline | 2012 |
A protective role of cumulus cells after short-term exposure of rat cumulus cell-oocyte complexes to lifestyle or environmental contaminants.
Topics: Animals; Benzhydryl Compounds; Caffeine; Cells, Cultured; Cumulus Cells; Dronabinol; Environmental Pollutants; Female; Gene Expression Regulation; Illicit Drugs; Life Style; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Oocytes; Phenols; Rats, Sprague-Dawley | 2017 |
Long-term monitoring of drug consumption patterns during the COVID-19 pandemic in a small-sized community in Brazil through wastewater-based epidemiology.
Topics: Amphetamine; Brazil; Caffeine; Cocaine; COVID-19; Dronabinol; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Pandemics; Substance Abuse Detection; Substance-Related Disorders; Wastewater; Wastewater-Based Epidemiological Monitoring; Water Pollutants, Chemical | 2022 |
Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants.
Topics: Adult; Caffeine; Cannabidiol; Cannabinoids; Cannabis; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dronabinol; Drug Interactions; Hallucinogens; Humans; Losartan; Midazolam; Omeprazole; Plant Extracts | 2023 |